Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 1207283-85-9
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of eravacycline during breastfeeding. The manufacturer states that breastfeeding is not recommended during treatment and for 4 days after the last dose. However, available literature indicates that there is not likely to be harm in short-term use of a eravacycline during lactation because the drug is 79 to 90% bound to plasma proteins, so milk levels are likely low and absorption by the infant is likely inhibited by the calcium in breastmilk. Short-term use of eravacycline acceptable in nursing mothers. If an infant is breastfed, monitor the infant for possible effects on the gastrointestinal flora, such as diarrhea, candidiasis (e.g., thrush, diaper rash) or rarely, blood in the stool indicating possible antibiotic-associated colitis. As a theoretical precaution, avoid prolonged or repeat courses during nursing.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Substance Identification
Substance Name
Eravacycline
CAS Registry Number
1207283-85-9
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Review Omadacycline.[Drugs and Lactation Database (...]Review Omadacycline.. Drugs and Lactation Database (LactMed®). 2006
- Review Tigecycline.[Drugs and Lactation Database (...]Review Tigecycline.. Drugs and Lactation Database (LactMed®). 2006
- Review Minocycline.[Drugs and Lactation Database (...]Review Minocycline.. Drugs and Lactation Database (LactMed®). 2006
- Review Tetracycline.[Drugs and Lactation Database (...]Review Tetracycline.. Drugs and Lactation Database (LactMed®). 2006
- Review Demeclocycline.[Drugs and Lactation Database (...]Review Demeclocycline.. Drugs and Lactation Database (LactMed®). 2006
- Eravacycline - Drugs and Lactation Database (LactMed®)Eravacycline - Drugs and Lactation Database (LactMed®)
- Taxonomy Links for Nucleotide (Select 38601877) (1)Taxonomy
Your browsing activity is empty.
Activity recording is turned off.
See more...